Epygon | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

28 results for “Epygon”

Trials

View all 19 →

First-In-Human Clinical Study for Treatment of Severe Mitral Valve INsufficiency With Epygon™ TRanscatheter Mitral VAlve System

40 participants · First posted Mar 1, 2021

Peyton Model In Midwifery Prenatal Education

64 participants · First posted Apr 15, 2026

To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)

214 participants · First posted May 11, 2018

Drugs

EPGN-2154

EPGN-1137

EPGN-696

Organizations

EPYGON

France

Epizon Pharma, Inc.

United States

Seiko Epson Corporation

Costa Rica

News

Affluent Medical Advances Three Medical Device Programs with Pivotal Trial Launch and FDA Regulatory Progress

PYGO2 Identified as Key Driver of 1q21+ Multiple Myeloma Progression and Potential Therapeutic Target

Page 1 of 3